PRME NASDAQ
Prime Medicine, Inc.
1W: -1.3%
1M: -5.3%
3M: -18.6%
YTD: -14.7%
1Y: -30.8%
3Y: -79.9%
$3.09
+0.08 (+2.66%)
Weekly Expected Move ±14.1%
$2
$3
$3
$3
$4
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
Smart Money Score
Watch
25
Insider—
Congress—
ETF Holdings—
Key Statistics
Market Cap$558.1M
52W Range2.67-6.94
Volume3,054,591
Avg Volume3,262,803
Beta2.27
Dividend$1.04
Analyst Ratings
Company Info
CEOAllan Reine
Employees146
SectorHealthcare
IndustryBiotechnology
IPO Date2022-10-20
Websiteprimemedicine.com
60 First Street
Cambridge, MA 02139
US
Cambridge, MA 02139
US
617-564-0013
About Prime Medicine, Inc.
Prime Medicine, Inc. operates as a biotechnology firm, dedicated to delivering genetic therapies for various diseases by strategically employing advanced gene editing technology. Central to their platform is the "Prime Editor" system, which combines a unique Prime Editor proteinâa hybrid composed of a Cas protein and a reverse transcriptase enzymeâwith a specialized pegRNA molecule. This pegRNA plays a crucial role by both guiding the Prime Editor to a precise location within the genome and providing the essential template for introducing the desired modification to the target DNA sequence. The company, founded in 2019, maintains its headquarters in Cambridge, Massachusetts.
Latest News
Prime Medicine, Inc. $PRME Shares Sold by Amova Asset Management Americas Inc.
Foghorn Therapeutics (FHTX) Surges 5.8%: Is This an Indication of Further Gains?
Prime Medicine Announces New Zealand Clearance of Clinical Trial Application for PM577a in H1069Q-mutated Wilson Disease
Ocular Therapeutix vs. Prime Medicine: Which Healthcare Stock Is a Better Buy in 2026?
As the GLP-1 race heats up, how can investors position themselves for the next wave of innovation?
Recent Insider Trades
| Name | Type | Shares | Price | Date |
|---|---|---|---|---|
| Chung Wendy | A-Award | 75,000 | $3.06 | 2026-06-05 |
| Cahill Thomas | A-Award | 75,000 | $3.06 | 2026-06-05 |
| Schenkein David P | A-Award | 75,000 | $3.06 | 2026-06-05 |
| Marrazzo Jeffrey D | A-Award | 75,000 | $3.06 | 2026-06-05 |
| NELSEN ROBERT | A-Award | 75,000 | $3.06 | 2026-06-05 |